Neurogene (NGNE) Interest & Investment Income (2013 - 2026)
Neurogene (NGNE) recorded Interest & Investment Income of $2.05 million in Q2 2026, down 30.1% from $2.93 million a year earlier and down 9.5% from the prior quarter.
Neurogene (NGNE) Interest & Investment Income (2013 - 2026) Analysis & Trends
On a TTM basis, Neurogene's Interest & Investment Income came in at $9.72 million as of Jun 30, 2026, down 5.1% year-over-year; for FY2025, it was $11.55 million, up 36.4% from FY2024.
- Annual Interest & Investment Income has increased for three straight years, with a three-year compound annual growth rate of 105.2% (FY2022 to FY2025).
- Across earlier years, Interest & Investment Income came in at $8.47 million in FY2024 (+186.9%), $2.95 million in FY2023 (+120.7%) and $1.34 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q3 2024.
- On a year-over-year basis, Interest & Investment Income rose in six of the last eight quarters, with growth averaging 57.9%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 198.6% in Q1 2024, against a decline of 30.1% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.26 million (Q1 2026), $2.67 million (Q4 2025) and $2.74 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Neurogene | 700.15 Mn | -397.16 Mn | - | 3.24 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.24 Mn |
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 2.67 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 3.21 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 781,000.00 |
| Sep 30, 2023 | 650,000.00 |
| Jun 30, 2023 | 743,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 571,000.00 |
| Sep 30, 2022 | 559,000.00 |
| Jun 30, 2022 | 194,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 5,000.00 |
Neurogene Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NGNE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();